CY1120801T1 - Μεθοδοι και αντιδραστηρια για τη διατηρηση της βιωσιμοτητας των καρκινικων κυτταρων σε χειρουργικως αφαιρουμενο ιστο - Google Patents

Μεθοδοι και αντιδραστηρια για τη διατηρηση της βιωσιμοτητας των καρκινικων κυτταρων σε χειρουργικως αφαιρουμενο ιστο

Info

Publication number
CY1120801T1
CY1120801T1 CY181100877T CY181100877T CY1120801T1 CY 1120801 T1 CY1120801 T1 CY 1120801T1 CY 181100877 T CY181100877 T CY 181100877T CY 181100877 T CY181100877 T CY 181100877T CY 1120801 T1 CY1120801 T1 CY 1120801T1
Authority
CY
Cyprus
Prior art keywords
reagents
methods
maintaining
cancer cell
cell viability
Prior art date
Application number
CY181100877T
Other languages
Greek (el)
English (en)
Inventor
Tony K Baker
Original Assignee
Truckee Applied Genomics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Truckee Applied Genomics Llc filed Critical Truckee Applied Genomics Llc
Publication of CY1120801T1 publication Critical patent/CY1120801T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • A01N1/12Chemical aspects of preservation
    • A01N1/122Preservation or perfusion media
    • A01N1/126Physiologically active agents, e.g. antioxidants or nutrients
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Physiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CY181100877T 2013-03-15 2018-08-23 Μεθοδοι και αντιδραστηρια για τη διατηρηση της βιωσιμοτητας των καρκινικων κυτταρων σε χειρουργικως αφαιρουμενο ιστο CY1120801T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361798627P 2013-03-15 2013-03-15
PCT/US2014/029198 WO2014144682A1 (en) 2013-03-15 2014-03-14 Methods and reagents for maintaining the viability of cancer cells in surgically removed tissue

Publications (1)

Publication Number Publication Date
CY1120801T1 true CY1120801T1 (el) 2019-12-11

Family

ID=51528685

Family Applications (1)

Application Number Title Priority Date Filing Date
CY181100877T CY1120801T1 (el) 2013-03-15 2018-08-23 Μεθοδοι και αντιδραστηρια για τη διατηρηση της βιωσιμοτητας των καρκινικων κυτταρων σε χειρουργικως αφαιρουμενο ιστο

Country Status (17)

Country Link
US (5) US9113623B2 (https=)
EP (2) EP3581643A1 (https=)
JP (1) JP6465857B2 (https=)
CN (2) CN105121629B (https=)
CA (1) CA2941929C (https=)
CY (1) CY1120801T1 (https=)
DK (1) DK2970878T3 (https=)
ES (1) ES2684582T3 (https=)
HR (1) HRP20181352T1 (https=)
HU (1) HUE039933T2 (https=)
LT (1) LT2970878T (https=)
PL (1) PL2970878T3 (https=)
PT (1) PT2970878T (https=)
RS (1) RS57900B1 (https=)
SI (1) SI2970878T1 (https=)
SM (1) SMT201800457T1 (https=)
WO (1) WO2014144682A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2684582T3 (es) 2013-03-15 2018-10-03 Truckee Applied Genomics, Llc Métodos y reactivos para mantener la viabilidad de células cancerosas en tejido eliminado quirúrgicamente
CN107002063A (zh) 2014-11-25 2017-08-01 生物辐射实验室股份有限公司 精氨酸提高聚合酶储存稳定性
CN107333750A (zh) * 2017-06-11 2017-11-10 成都吱吖科技有限公司 一种长时血液细胞稳定剂
EP4089180B1 (en) 2019-09-17 2025-06-25 Longhorn Vaccines and Diagnostics, LLC Multipurpose compositions for collecting and transporting biological material
WO2022010916A1 (en) * 2020-07-07 2022-01-13 Truckee Applied Genomics, Llc Cell preservation reagents and methods of use
CN117063915B (zh) * 2023-08-17 2026-02-24 镜像绮点(上海)细胞技术有限公司 原代肿瘤细胞冻存液

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409826A (en) * 1993-06-08 1995-04-25 Coulter Corporation Preserved, non-infectious control cells prepared by the modulation or modification of normal cells
JP2000509018A (ja) * 1996-03-26 2000-07-18 イーライ・リリー・アンド・カンパニー 肥満タンパク質製剤
US20010007673A1 (en) 1999-11-12 2001-07-12 Merrill Seymour Goldenberg Sustained-release delayed gels
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
US20080064108A1 (en) 1997-12-10 2008-03-13 Tony Baker Urine Preservation System
WO1999029904A2 (en) 1997-12-10 1999-06-17 Sierra Diagnostics, Inc. Methods and reagents for preservation of dna in bodily fluids
WO2002046368A1 (fr) * 2000-12-04 2002-06-13 Humantec Ltd. Liquide de conservation de cellules et procede de conservation de cellules dans lequel ledit liquide est utilise
KR20020066778A (ko) 2001-02-13 2002-08-21 한국과학기술연구원 체내 난흡수 물질의 흡수촉진용 조성물과 제형 및 그의제조방법
WO2008111981A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation of macromolecules
AU2003300899A1 (en) * 2002-12-12 2004-06-30 Oncotech, Inc. Genes related to sensitivity and resistance to chemotherapeutic drug treatment
US8793895B2 (en) * 2006-02-10 2014-08-05 Praxair Technology, Inc. Lyophilization system and method
CN101617045A (zh) 2006-09-12 2009-12-30 谢拉分子公司 使用离液剂的缓冲溶液去除核酸的分子分析干扰物
US8080645B2 (en) * 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8652782B2 (en) * 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
JP2010508090A (ja) 2006-10-27 2010-03-18 シエラ モレキュラー コーポレイション 貫通可能な隔壁キャップ
ES2394815T3 (es) 2006-12-13 2013-02-05 F. Hoffmann-La Roche Ag Utilización de TDE para el aislamiento de ácidos nucleicos
AU2008224883A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation and/or stabilization of a cell and/or macromolecule
KR20100102607A (ko) * 2007-11-12 2010-09-24 바이파 사이언스 인코포레이티드 Parp 억제제를 단독으로 사용하거나 항종양제와 병용하여 자궁암 및 난소암을 치료하는 방법
US20100003748A1 (en) * 2008-07-03 2010-01-07 Tony Baker Compositions, systems, and methods for stabilization of a cell and/or macromolecule
WO2010028156A2 (en) 2008-09-04 2010-03-11 Board Of Regents, The University Of Texas System Dual modality detection of apoptosis
US9133343B2 (en) 2009-11-30 2015-09-15 Enzo Biochem, Inc. Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications
CN102318597B (zh) * 2011-08-19 2013-04-03 张雪云 一种液基细胞保存液组合物及其制备方法
ES2684582T3 (es) 2013-03-15 2018-10-03 Truckee Applied Genomics, Llc Métodos y reactivos para mantener la viabilidad de células cancerosas en tejido eliminado quirúrgicamente

Also Published As

Publication number Publication date
SMT201800457T1 (it) 2018-11-09
DK2970878T3 (en) 2018-09-03
US20140272921A1 (en) 2014-09-18
US10772318B2 (en) 2020-09-15
PL2970878T3 (pl) 2019-01-31
EP2970878A4 (en) 2016-08-03
CN112806352A (zh) 2021-05-18
US9565852B2 (en) 2017-02-14
EP2970878A1 (en) 2016-01-20
WO2014144682A4 (en) 2014-12-24
HRP20181352T1 (hr) 2018-12-14
CA2941929A1 (en) 2014-09-18
WO2014144682A1 (en) 2014-09-18
JP2016512693A (ja) 2016-05-09
ES2684582T3 (es) 2018-10-03
US9113623B2 (en) 2015-08-25
US9445586B2 (en) 2016-09-20
WO2014144682A8 (en) 2015-08-13
US20170215410A1 (en) 2017-08-03
US20150327539A1 (en) 2015-11-19
JP6465857B2 (ja) 2019-02-06
CA2941929C (en) 2021-02-23
CN105121629B (zh) 2020-12-18
LT2970878T (lt) 2018-11-12
SI2970878T1 (sl) 2019-02-28
RS57900B1 (sr) 2019-01-31
CN105121629A (zh) 2015-12-02
PT2970878T (pt) 2018-10-09
US9949474B2 (en) 2018-04-24
EP3581643A1 (en) 2019-12-18
US20150230454A1 (en) 2015-08-20
HUE039933T2 (hu) 2019-02-28
EP2970878B1 (en) 2018-05-23
US20160235055A1 (en) 2016-08-18
HK1220481A1 (en) 2017-05-05

Similar Documents

Publication Publication Date Title
CY1120801T1 (el) Μεθοδοι και αντιδραστηρια για τη διατηρηση της βιωσιμοτητας των καρκινικων κυτταρων σε χειρουργικως αφαιρουμενο ιστο
CO2019007258A2 (es) Arn guía modificados
EP3597733A4 (en) THREE-DIMENSIONAL CULTURE OF PRIMARY CANCER CELLS USING TUMOR TISSUE
CY1123093T1 (el) Φαρμακοφορο για την επαγωγη του trail
MX375678B (es) Metodo para producir celulas progenitoras hepaticas adultas.
MX369521B (es) Metodos de creacion de bancos de celulas de alta densidad.
MX2019012311A (es) Metodos y composiciones para modificaciones geneticas dirigidas y metodos de uso.
MX2017010746A (es) Composicion y metodos para la expresion regulada de un complejo de arn guia/endonucleasa cas.
PH12018500927B1 (en) Liver-specific constructs, factor viii expression cassettes and methods of use thereof
MX382223B (es) Regulacion de expresion genica mediada por nucleasa.
UY36400A (es) Péptidos macrocíclicos como inhibidores de las interacciones entre las proteínas pd-1/pd-l1 y cd80/pd-l1 y sus funciones inmunomoduladoras
PH12017500826A1 (en) Bioreactor using microalgae
GB2555728A (en) Cancer cell enrichment system
MX2017016088A (es) Oligonucleotidos multi-conjugados definidos.
BR112017011582A2 (pt) fibroblasto de embrião de galinha imortalizado, cultura de célula, métodos para preparação de um cef importalizado, para a replicação de um vetor viral aviário e para a preparação de uma vacina, e, vacina.
MX375786B (es) Biosintesis microbiana de ergotioneina.
GT201500245A (es) Factores de transcripción que regulan la biosíntesis de la nicotina en el tabaco
EA202190326A2 (ru) Не содержащая сыворотки среда для культивирования клеток
MX2020009670A (es) Metodos de cultivo por perfusion y usos de los mismos.
EP3242930A4 (en) MICROFLUIDIC CELL CULTURE OF TUMOR CELL SPHEROIDS FROM PATIENTS
EP3147349A4 (en) Bioreactor for three-dimensional tissue perfusion culture
MX2017003651A (es) Métodos de establecimiento de bancos de células de densidad ultra-alta.
CR20150543A (es) Método de tratamiento de páncreas e hígado para condiciones por transplante de células madre en paredes de conducto biliar
MX2018006373A (es) Produccion de virus en cultivos celulares.
PH12020551126A1 (en) Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing